Putnam Investments’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Putnam Investments’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-459,213	Closed	-$11.7M	–	1187
2018 Q2	$11.7M	Sell	459,213 -2,267	-0.5%	-$52.9K	0.03%	343
2018 Q1	$9.3M	Buy	+461,480	New	+$10.8M	0.02%	381
2016 Q4	–	Sell	-67,324	Closed	-$1.89M	–	1316
2016 Q3	$1.89M	Hold	67,324	–	–	﹤0.01%	859
2016 Q2	$2.36M	Sell	67,324 -34,008	-34%	-$1.07M	0.01%	876
2016 Q1	$2.78M	Hold	101,332	–	–	0.01%	858
2015 Q4	$3.47M	Hold	101,332	–	–	0.01%	801
2015 Q3	$2.91M	Sell	101,332 -439	-0.4%	-$18.8K	0.01%	877
2015 Q2	$4.55M	Sell	101,771 -1,438	-1%	-$54.1K	0.01%	765
2015 Q1	$3.57M	Sell	103,209 -322,726	-76%	-$8.78M	0.01%	887
2014 Q4	$11.7M	Buy	+425,935	New	+$10.3M	0.02%	461

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Putnam Investments's DPLO Position: Q3 2018 in Review

Putnam Investments sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2018, closing a stake of 459,213 shares — an estimated $11.7M sold.

Putnam Investments first reported a position in DPLO in Q4 2014 and held it in 10 quarters. The position peaked at $11.7M in Q2 2018. 178 funds tracked by Wall St. Rank hold DPLO as of Q3 2018.

Putnam Investments reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2018 after selling out during the quarter.
Putnam Investments sold 459,213 DIPLOMAT PHARMACY, INC. shares in Q3 2018, an estimated $11.7M.
Putnam Investments first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 10 quarters.
Putnam Investments's DIPLOMAT PHARMACY, INC. position peaked at $11.7M in Q2 2018.
178 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2018.

Based on Putnam Investments's 13F filing for Q3 2018, filed 14 Nov 2018.